Stay updated on PK Interaction Study Sitravatinib P-gp Modulators Clinical Trial
Sign up to get notified when there's something new on the PK Interaction Study Sitravatinib P-gp Modulators Clinical Trial page.

Latest updates to the PK Interaction Study Sitravatinib P-gp Modulators Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov page now displays the Phase 1 study record assessing how itraconazole and rifampin affect sitravatinib in healthy adults. It includes the study’s eligibility requirements, treatment arms, outcome measures, location, and record dates.SummaryDifference46%

- Check11 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The ClinicalTrials.gov page still shows a 403 error, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check32 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now presents a 403 Forbidden error, indicating a permissions/server issue that prevents loading the study details page.SummaryDifference0.5%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, suggesting the study record is inaccessible; surrounding content appears largely replaced by the error state, indicating a access issue rather than substantive study updates.SummaryDifference18%

Stay in the know with updates to PK Interaction Study Sitravatinib P-gp Modulators Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK Interaction Study Sitravatinib P-gp Modulators Clinical Trial page.